Press Releases

All Releases
View Summary Myriad Genetics to Announce Fiscal Fourth Quarter and Fiscal Year 2011 Results on Tuesday, August 9, 2011
Jul 19, 2011
PDF 12.3 KB Add to Briefcase
View Summary OnDose® Study Demonstrates Need for Improved Dosing Approach for Colorectal Cancer Patients
Jun 9, 2011
PDF 16.1 KB Add to Briefcase
View Summary Myriad's PROLARIS(R) Test Shown to Significantly Predict Prostate Cancer Outcome From Needle Biopsy Tissue
Jun 6, 2011
PDF 16.7 KB Add to Briefcase
View Summary Myriad Genetics Completes Acquisition of Rules-Based Medicine
Jun 1, 2011
PDF 15.3 KB Add to Briefcase
View Summary Myriad Genetics to Present at the Jefferies Global Healthcare Conference
May 24, 2011
PDF 21.3 KB Add to Briefcase
View Summary Myriad Genetics Announces Presentation of Prostate Cancer Study at American Society for Clinical Oncology Annual Meeting
May 18, 2011
PDF 22.5 KB Add to Briefcase
View Summary Myriad Genetics Licenses Novel Technology From Chronix Biomedical
May 10, 2011
PDF 24.9 KB Add to Briefcase
View Summary Myriad Genetics Reports Fiscal 2011 Third Quarter Results
May 3, 2011
PDF 30.2 KB Add to Briefcase
View Summary Myriad Genetics Announces Agreement to Acquire Rules-Based Medicine
Apr 27, 2011
PDF 24.5 KB Add to Briefcase
View Summary Myriad Genetics and BioMarin Pharmaceutical Inc. Enter Into Agreement
Apr 6, 2011
PDF 24.4 KB Add to Briefcase
View Summary Myriad Genetics to Announce Fiscal Third Quarter Financial Results on Tuesday, May 3, 2011
Apr 5, 2011
PDF 19.3 KB Add to Briefcase
View Summary Myriad Announces New $100 Million Share Repurchase Program
Mar 1, 2011
PDF 22.3 KB Add to Briefcase
View Summary Myriad Genetics to Present at the Citi Global Healthcare Conference
Feb 16, 2011
PDF 21.1 KB Add to Briefcase
View Summary Myriad's PROLARIS(TM) Test Shown to Significantly Predict Prostate Cancer Outcome
Feb 9, 2011
PDF 22.5 KB Add to Briefcase
View Summary Myriad Genetics Reports Fiscal 2011 Second Quarter Results
Jan 27, 2011
PDF 29.8 KB Add to Briefcase
View Summary Myriad Genetics to Report Fiscal 2011 Second Quarter Financial Results on January 27
Jan 10, 2011
PDF 18.9 KB Add to Briefcase
View Summary Myriad Genetics to Present at the 29th Annual J.P. Morgan Healthcare Conference
Dec 22, 2010
PDF 20.9 KB Add to Briefcase
View Summary Myriad Genetics Launches PANEXIA, New Predictive Test for Hereditary Pancreatic and Related Cancers
Dec 20, 2010
PDF 22.6 KB Add to Briefcase
View Summary Newly Published Study Finds High Prevalence of BRCA Mutations in Breast Carcinoma in Situ (CIS)
Dec 14, 2010
PDF 24.9 KB Add to Briefcase
View Summary Myriad Acquires Novel Technology From Melanoma Diagnostics
Dec 8, 2010
PDF 23.1 KB Add to Briefcase
Showing 121-140 of 307 Page: 1 ... 3 4 5 6 7 8 9 10 11 ... 16  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Stock Quote (NASDAQ:MYGN)

Price:
37.63
Change:
+ 0.46
Open:
37.39
Previous Close:
37.17
Day High:
38.37
Day Low:
37.20
52 Week High:
42.50
52 Week Low:
20.02
Volume:
406,300
4:00 PM ET on Jul 23, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Investor Contact

Scott Gleason
(801) 584-1143
sgleason@myriad.com

Media Contact

Ron Rogers
Corporate Communications and Media Relations
(801) 584-3065
rrogers@myriad.com